Natural approaches in metabolic syndrome management
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome (MetS) is characterized as a group of cardiometabolic risk factors that raise the risk for heart disease and other health problems, such as diabetes mellitus and stroke. Treatment strategies include pharmacologic interventions and supplementary (or "alternative") treatments. Nutraceuticals are derived from food sources (isolated nutrients, dietary supplements and herbal products) that are purported to provide health benefits, in addition to providing basic nutritional value. Nutraceuticals are claimed to prevent chronic diseases, improve health, delay the aging process, increase life expectancy, and support the structure and function of the body. The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment. This review focuses on widely marketed nutraceuticals (namely polyphenols, omega-3 fatty acids, macroelements and vitamins) with clinically demonstrated effects on more than one component of MetS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889 · cited 19×
“Metabolic syndrome (MetS) is defined as the coexistence of risk factors of metabolic origin (insulin resistance, hyperinsulinemia, impaired glucose tolerance, type 2 diabetes mellitus, visceral obesity, atherogenic dyslipidaemia and/or, high blood pressure) that elevate risk for cardiovascular disease [1–3].”
BackgroundInfluentialRetractedMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Free radicals, antioxidants and functional foods: impact on human health
Lobo, V, Patil, A., Phatak, A., & Chandra, N. (2010) · Pharmacognosy Reviews · doi:10.4103/0973-7847.70902 · Cited by 5,435 · cited 2×
“Some studies suggest that omega-3 polyunsaturated fatty acids reduce the damage caused by oxidative stress and restore free radical homeostasis [92, 93].”
BackgroundO'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Free Radicals, Antioxidants in Disease and Health
Department of Pharmacy, L. S. P. C. H., Pham-Huy, L. A., He, H., Department of Analytical Chemistry, C. P. U., Pham-Huyc, C., & Laboratory of Toxicology, F. O. P. (2008) · International Journal of Biomedical Science · doi:10.59566/ijbs.2008.4089 · Cited by 3,058 · cited 1×
“Some studies suggest that omega-3 polyunsaturated fatty acids reduce the damage caused by oxidative stress and restore free radical homeostasis [92, 93].”
BackgroundNiacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Beneficial Effects of Green Tea—A Review
Cabrera, C., Artacho, R., & Giménez, R. (2006) · Journal of the American College of Nutrition · doi:10.1080/07315724.2006.10719518 · Cited by 1,904
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668 · cited 1×
“Previously available randomized clinical trial data assessing the clinical efficacy of niacin have been challenged by results from AIM-HIGH and HPS-2 THRIVE, which failed to demonstrate a reduction in CVD event incidence in patients with established CVD treated with niacin as an adjunct to intensive simvastatin therap…”
ResultMetabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565 · cited 1×
“Arch Med Sci 2, March / 2018 423 cerebrovascular disease [4]; (2) insulin resistance contributes to higher levels of serum insulin and glucose, precursors to the development of diabetes mellitus [5]; (3) hyperinsulinemia results in excessive renal sodium retention and elevations in blood pressure [6]; (4) alteration o…”
BackgroundSesso, H. D. (2008) · JAMA · doi:10.1001/jama.2008.600 · Cited by 913
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
Stern, M. P., Williams, K., González-Villalpando, C., Hunt, K. J., & Haffner, S. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2676 · Cited by 735 · cited 1×
“Arch Med Sci 2, March / 2018 423 cerebrovascular disease [4]; (2) insulin resistance contributes to higher levels of serum insulin and glucose, precursors to the development of diabetes mellitus [5]; (3) hyperinsulinemia results in excessive renal sodium retention and elevations in blood pressure [6]; (4) alteration o…”
BackgroundStudy of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) · The Lancet · doi:10.1016/s0140-6736(10)60310-8 · Cited by 558
Huang, T., Yang, B., Zheng, J., Li, G., Wahlqvist, M. L., & Li, D. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000337301 · Cited by 382 · cited 4×
“Circulating desphospho-uncarboxylated matrix Gla-protein (dp-ucMGP) as well as acute phase markers IL-6, hs-CRP, TNF-α and markers for endothelial dysfunction (vascular cell adhesion molecule-1 (VCAM-1) and E-selectin), and advanced glycation end products (AGEs) were measured [105].”
BackgroundInfluentialKwak (2012) · doi:10.1001/archinternmed.2012.262 · Cited by 368
Ballantyne, C. M., Bays, H. E., Kastelein, J. J., Stein, E., Isaacsohn, J. L., Braeckman, R. A., & Soni, P. N. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.05.031 · Cited by 342
Serban, M.-C., Colantonio, L. D., Manthripragada, A. D., Monda, K. L., Bittner, V. A., Banach, M., Chen, L., Huang, L., Dent, R., Kent, S. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.12.036 · Cited by 318 · cited 1×
“Natural products can also be useful in the therapy with metabolic syndrome and statin intolerance; especially MetS might increase the risk of statin intolerance – via liver dysfunction/steatosis [134, 135].”
BackgroundSelf-citationSerban, M., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Antal, D., Andrica, F., Ahmed, A., Aronow, W. S., Muntner, P., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002713 · Cited by 317
Self-citationTriglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Toth, P. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s104369 · Cited by 237 · cited 1×
“These studies should provide valuable information on the utility of omega-3 fatty acids in combination with statin therapy in high-risk patients with TG levels of 200–500 mg/dl [71].”
BackgroundSelf-citationRied, K., & Fakler, P. (2014) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s51434 · Cited by 198 · cited 1×
“High levels of allicin and sulfur reduce blood pressure [41].”
BackgroundDairy Consumption and the Incidence of Hyperglycemia and the Metabolic Syndrome
Fumeron, F., Lamri, A., Abi Khalil, C., Jaziri, R., Porchay-Baldérelli, I., Lantieri, O., Vol, S., Balkau, B., Marre, M., & the Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study Group (2011) · Diabetes Care · doi:10.2337/dc10-1772 · Cited by 167 · cited 2×
“Calcium ↓ Adiponectin [88] ↓ Cholesterol levels [85] ↓ IFG or diabetes [86]”
BackgroundSerban, M.-C., Sahebkar, A., Dragan, S., Stoichescu-Hogea, G., Ursoniu, S., Andrica, F., & Banach, M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2015.09.007 · Cited by 156
Self-citationJurgoński, A., Juśkiewicz, J., & Zduńczyk, Z. (2008) · Plant Foods for Human Nutrition · doi:10.1007/s11130-008-0087-7 · Cited by 132
Barrios, V., Escobar, C., Cicero, A. F. G., Burke, D., Fasching, P., Banach, M., & Bruckert, E. (2017) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2016.10.003 · Cited by 96
Ursoniu, S., Sahebkar, A., Serban, M.-C., & Banach, M. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.50960 · Cited by 80
Self-citationAnti-angiogenic effect of high doses of ascorbic acid
Mikirova, N. A., Ichim, T. E., & Riordan, N. H. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-50 · Cited by 78
Sahebkar, A., Serban, C., Ursoniu, S., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2015.06.009 · Cited by 52
Self-citationChristenson, J., Whitby, S. J., Mellor, D., Thomas, J., McKune, A., Roach, P. D., & Naumovski, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0035 · Cited by 47
Cited by
Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases
Forni, C., Facchiano, F., Bartoli, M., Pieretti, S., Facchiano, A., D’Arcangelo, D., Norelli, S., Valle, G., Nisini, R., Beninati, S., et al. (2019) · BioMed Research International · doi:10.1155/2019/8748253 · Cited by 513
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465
Cicero, A. F. G., Fogacci, F., Veronesi, M., Strocchi, E., Grandi, E., Rizzoli, E., Poli, A., Marangoni, F., & Borghi, C. (2020) · Nutrients · doi:10.3390/nu12030686 · Cited by 106
“These results are of particular interest, also considering that the observed effect is larger than the one expected after the administration of most available lipid-lowering nutraceuticals [21,22].”
BackgroundSelf-citationCastro-Barquero, S., Tresserra-Rimbau, A., Vitelli-Storelli, F., Doménech, M., Salas-Salvadó, J., Martín-Sánchez, V., Rubín-García, M., Buil-Cosiales, P., Corella, D., Fitó, M., et al. (2020) · Nutrients · doi:10.3390/nu12030689 · Cited by 106
Moradi, S., Ziaei, R., Foshati, S., Mohammadi, H., Nachvak, S. M., & Rouhani, M. H. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102211 · Cited by 88
Metadata
- Authors
- Patti, A. M., Al-Rasadi, K., Giglio, R. V., Nikolic, D., Mannina, C., Castellino, G., Chianetta, R., Banach, M., Cicero, A. F., Lippi, G., Montalto, G., Rizzo, M., & Toth, P. P.
- Venue
- Archives of Medical Science
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2018
- Volume
- 14
- Issue
- 2
- Pages
- 422-441
- ISSN
- 1734-1922 (ISSN-L)
- OpenAlex
- W2737757244
- Cited by
- 139
- References
- 30
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.